Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.40653 | 55 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.23491 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.23565 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.11821 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.16961 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.57475 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.76795 | 62 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.21464 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.19184 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.19309 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.22815 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16574 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.26415 | 52 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.23747 | 51 |